FdaApplication
ANDA 083770
Identifiers
- fda_app_no: ANDA083770
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABORATORIES INC |
| application_type | ANDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE | 25MG;15MG;0.1MG | TABLET;ORAL |
1 product